Effect of xeroderma pigmentosum group D gene on proliferation of hu-man umbilical arterial smooth muscle cells induced by Ox-LDL / 中国病理生理杂志

AIM:To investigate the effects of xeroderma pigmentosum group D ( XPD) gene on the prolifera-tion of human umbilical arterial smooth muscle cells ( HUASMCs) induced by oxidized low-density lipoprotein ( Ox-LDL) . METHODS:The recombinant plasmid pEGFP-N2/XPD was transfected into HUASMCs by liposome .The cells were di-vided into blank control group , pEGFP-N2 group, pEGFP-N2/XPD group, Ox-LDL group, Ox-LDL+pEGFP-N2 group and Ox-LDL+pEGFP-N2/XPD group.The proliferation rate of the cells was detected by MTT and EdU assays .The apop-totic rate and cell cycle distribution were analyzed by flow cytometry .The protein levels of XPD, caspase-3, Bcl-2 and Bax were determined by Western blot .RESULTS:Compared with blank control group , the expression of XPD was increased in pEGFP-N2/XPD group (P<0.05).According to the results of MTT and EdU assays , the cell proliferation in pEGFP-N2/XPD group was reduced compared with blank control group (P<0.05).Compared with Ox-LDL group, the cell prolifera-tion in Ox-LDL+pEGFP-N2/XPD group was significantly inhibited (P<0.05).According to the results of flow cytome-try, the cell proportion of S phase decreased and the G 0/G1-phase cell proportion increased significantly in pEGFP-N2/XPD group and Ox-LDL+pEGFP-N2/XPD group compared with blank control group and Ox-LDL group, repectively (P<0.05).Compared with blank control group and Ox-LDL group, the protein level of Bcl-2 decreased and the protein levels of Bax and cleaved caspase-3 increased in pEGFP-N2/XPD group and Ox-LDL +pEGFP-N2/XPD group, respectively (P<0.05).CONCLUSION:XPD inhibits the proliferation of HUASMCs and promotes their apoptosis , and reduces the promoting effect of Ox-LDL on the proliferation of HUVSMCs .XPD may be the target for treatment of atherosclerosis .

Relationship between Chinese medicine syndrome and peripheral blood stem cells in patients with ischemic heart failure / 中国中西医结合杂志

<p><b>OBJECTIVE</b>To explore the relationship of Chinese medicine syndromes with heart function and peripheral blood stem cells (PBSCs) count in patients with ischemic heart failure (IHF).</p><p><b>METHODS</b>Clinical materials of 208 inpatients with IHF were collected and the characteristics of their Chinese medicine syndromes were summarized, the number of PBSC was counted with flow cytometer, and the differences of left ventricular ejection fraction (LVEF), N-terminal brain natriuretic peptide (NT-proBNP) and PBSC count related to various syndrome factors and syndrome types were compared using One-way ANOVA.</p><p><b>RESULTS</b>LVEF >50% was found in patients with syndromes of qi-deficiency, yin-deficiency, turbid-phlegm and blood-stasis, while <50% in those of yang-deficiency and fluid-retention, showing significant differences between the former four syndromes and the latter two syndromes. Compared them with syndromes of qi-deficiency, yin-deficiency, turbid-phlegm and blood-stasis, NT-proBNP in the yang deficiency group and water retention group was higher (P<0.01); the PBSC count in patients with yang-deficiency syndrome factor was the least, which was significantly different to that in patients with the former four syndromes (P<0.01, P<0.05), but it was insignificantly different to that with water-retention; LVEF >50% in syndrome types of Xin-Fei qi-deficiency, deficiency of qi and yin, qi-deficiency with blood-stasis and phlegm accumulation in Fei, but <50% in syndrome types of Xin-Shen yang-deficiency and yang-deficiency with water-retention. Compared them with syndrome types of Xin-Fei qi-deficiency, deficiency of qi and yin, qi-deficiency with blood-stasis and phlegm accumulation in Fei, the difference was statistically significant (P<0.05, P<0.01); The highest level of NT-proBNP was shown in syndrome type of yang-deficiency with water-retention, the secondary was in Xin-Shen yang-deficiency, and all showed significant differences as compared with that in other syndrome types (P<0.05); while difference of PBSC count in patients with various syndrome types showed insignificance (P>0.05).</p><p><b>CONCLUSION</b>Chinese medicine syndrome is correlated with heart function and PBSC count in patients with IHF, and the PBSC count in patients with characteristics of yang-deficiency syndrome is lower.</p>

Association between the number of peripheral blood stem cells and cardiac function index in patients with ischemic heart failure / 中华心血管病杂志

<p><b>OBJECTIVE</b>To observe the association between the number of peripheral blood stem cells (PBSC) and cardiac function index (NYHA grade, left ventricular ejection fraction, LVEF, N-terminal-proB-type Natriuretic Peptide, NT-pro BNP) in patients with ischemic heart failure (IHF).</p><p><b>METHODS</b>A total of 199 patients hospitalized in our department between August 2007 and April 2008 due to IHF were included in this study. NYHA grade, LVEF (measured by echocardiography), plasma NT-proBNP and number of PBSC were analyzed.</p><p><b>RESULTS</b>PBSC number was significantly decreased in proportion with increasing NYHA grade and PBSC number was significantly lower in patients with NYHA IV than that with class II and III (all P<0.01). LVEF was positively correlated with PBSC number (r = 0.35, P = 0.001), NT-proBNP was negatively correlated with PBSC number (r = - 0.39, P = 0.009). Multiple regression analysis showed that LVEF and NT-proBNP were major determinants of PBSC (Beta = 0.14, - 0.25, 95% CI = -0.01 - 0.02, -0.18 - -0.04, P<0.05, P<0.01).</p><p><b>CONCLUSION</b>PBSC number was significantly correlated to cardiac function in IHF patients.</p>

Influence of shenfu injection on heart function and bone marrow stem cell mobilization in patients with chronic heart failure of coronary heart disease / 中国中西医结合杂志

<p><b>OBJECTIVE</b>To explore the influence of Shenfu Injection (SFI) on heart function and bone marrow stem cell mobilization in patients with chronic heart failure.</p><p><b>METHODS</b>Sixty-three patients of coronary heart disease (CHD) with chronic heart failure were randomly assigned to the control group (32 cases) and the treatment group (31 cases). Western medical conventional treatment was given to all patients, but SFI was given once a day to patients in the treatment group additionally at the dose of 40 mL by dripping after dilution. After one week of treatment, the cardiac function indexes, including left ventricular ejection fraction (LVEF), stroke volume (SV) and cardiac output (CO), as well as the number of CD34+ stem cells in the peripheral blood were detected and compared.</p><p><b>RESULTS</b>After treatment, all the three cardiac function indexes were improved obviously in both groups (P < 0.01), but the improvement in the treatment group was more significant than that in the control group (P < 0.05). CD34+ stem cells were insignificantly changed in the control group after treatment, while it significantly increased in the treatment group (P < 0.01), showing significant difference between groups.</p><p><b>CONCLUSION</b>SFI can significantly enhance the systolic function of heart, increase the number of CD34+ stem cells in the peripheral blood, and promote the mobilization of bone marrow stem cells, which is possibly one of its acting mechanisms for improving the cardiac function.</p>